How Should We Assign Large Infiltrative Hepatocellular Carcinomas for Staging?
Infiltrative gross morphology of hepatocellular carcinoma (HCC) is known to be associated with poor prognosis, but this is not considered for staging. A total of 774 HCC patients who underwent curative liver resection were retrospectively reviewed and the prognostic significance of infiltrative type...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/9/2589 |
id |
doaj-9a8717df3ce44b22ab149b878c0ca500 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yoo Jin Lee Yoo Ra Lee Chung Gyo Seo Hyun Gil Goh Tae Hyung Kim Sun Young Yim Na Yeon Han Jae Min Lee Hyuk Soon Choi Eun Sun Kim Bora Keum Hyonggin An Beomjin Park Yeon Seok Seo Hyung Joon Yim Ji Hoon Kim Young Dong Yu Dong Sik Kim Yoon Tae Jeen Hoon Jai Chun Hong Sik Lee Chang Duck Kim Soon Ho Um |
spellingShingle |
Yoo Jin Lee Yoo Ra Lee Chung Gyo Seo Hyun Gil Goh Tae Hyung Kim Sun Young Yim Na Yeon Han Jae Min Lee Hyuk Soon Choi Eun Sun Kim Bora Keum Hyonggin An Beomjin Park Yeon Seok Seo Hyung Joon Yim Ji Hoon Kim Young Dong Yu Dong Sik Kim Yoon Tae Jeen Hoon Jai Chun Hong Sik Lee Chang Duck Kim Soon Ho Um How Should We Assign Large Infiltrative Hepatocellular Carcinomas for Staging? Cancers hepatocellular carcinoma AJCC 8th staging system gross morphology infiltrative type nodular type overall survival |
author_facet |
Yoo Jin Lee Yoo Ra Lee Chung Gyo Seo Hyun Gil Goh Tae Hyung Kim Sun Young Yim Na Yeon Han Jae Min Lee Hyuk Soon Choi Eun Sun Kim Bora Keum Hyonggin An Beomjin Park Yeon Seok Seo Hyung Joon Yim Ji Hoon Kim Young Dong Yu Dong Sik Kim Yoon Tae Jeen Hoon Jai Chun Hong Sik Lee Chang Duck Kim Soon Ho Um |
author_sort |
Yoo Jin Lee |
title |
How Should We Assign Large Infiltrative Hepatocellular Carcinomas for Staging? |
title_short |
How Should We Assign Large Infiltrative Hepatocellular Carcinomas for Staging? |
title_full |
How Should We Assign Large Infiltrative Hepatocellular Carcinomas for Staging? |
title_fullStr |
How Should We Assign Large Infiltrative Hepatocellular Carcinomas for Staging? |
title_full_unstemmed |
How Should We Assign Large Infiltrative Hepatocellular Carcinomas for Staging? |
title_sort |
how should we assign large infiltrative hepatocellular carcinomas for staging? |
publisher |
MDPI AG |
series |
Cancers |
issn |
2072-6694 |
publishDate |
2020-09-01 |
description |
Infiltrative gross morphology of hepatocellular carcinoma (HCC) is known to be associated with poor prognosis, but this is not considered for staging. A total of 774 HCC patients who underwent curative liver resection were retrospectively reviewed and the prognostic significance of infiltrative type HCC was assessed using the American Joint Committee on Cancer (AJCC) and Barcelona Clinic Liver Cancer (BCLC) staging systems. Seventy-four patients (9.6%) had infiltrative HCCs with a higher proportion of multifocal tumors, larger tumors, vessel invasion, increased tumor marker levels, and advanced T-stages than those with nodular HCC (all, <i>p</i><i> </i>< 0.01). Infiltrative morphology was independently associated with lower overall survival (OS), but its impact was significant when the tumor size was ≥ 4 cm (<i>p</i><i> </i>< 0.001). Under current AJCC and BCLC staging criteria, these large infiltrative HCCs were associated with significantly worse OS in early AJCC T-stages (T1b/T2, <i>p</i><i> </i>< 0.001) and BCLC stage A/B (both, p < 0.01) but not in late AJCC (T3/T4) and BCLC C. The reassignment of this subtype to T3 and T4 increased the discriminatory ability of AJCC T-staging with lower AIC values (3090 and 3088 vs. 3109) and higher c-index (0.69 and 0.69 vs. 0.67), respectively (both, p < 0.001). Similarly, the reassignment of large infiltrative HCC to BCLC stages B and C also improved the prognostic performance. Large infiltrative HCCs should be assigned to more advanced stages in current staging systems for their prognostic impact. |
topic |
hepatocellular carcinoma AJCC 8th staging system gross morphology infiltrative type nodular type overall survival |
url |
https://www.mdpi.com/2072-6694/12/9/2589 |
work_keys_str_mv |
AT yoojinlee howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging AT yooralee howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging AT chunggyoseo howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging AT hyungilgoh howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging AT taehyungkim howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging AT sunyoungyim howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging AT nayeonhan howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging AT jaeminlee howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging AT hyuksoonchoi howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging AT eunsunkim howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging AT borakeum howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging AT hyongginan howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging AT beomjinpark howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging AT yeonseokseo howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging AT hyungjoonyim howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging AT jihoonkim howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging AT youngdongyu howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging AT dongsikkim howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging AT yoontaejeen howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging AT hoonjaichun howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging AT hongsiklee howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging AT changduckkim howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging AT soonhoum howshouldweassignlargeinfiltrativehepatocellularcarcinomasforstaging |
_version_ |
1724801771703894016 |
spelling |
doaj-9a8717df3ce44b22ab149b878c0ca5002020-11-25T02:36:02ZengMDPI AGCancers2072-66942020-09-01122589258910.3390/cancers12092589How Should We Assign Large Infiltrative Hepatocellular Carcinomas for Staging?Yoo Jin Lee0Yoo Ra Lee1Chung Gyo Seo2Hyun Gil Goh3Tae Hyung Kim4Sun Young Yim5Na Yeon Han6Jae Min Lee7Hyuk Soon Choi8Eun Sun Kim9Bora Keum10Hyonggin An11Beomjin Park12Yeon Seok Seo13Hyung Joon Yim14Ji Hoon Kim15Young Dong Yu16Dong Sik Kim17Yoon Tae Jeen18Hoon Jai Chun19Hong Sik Lee20Chang Duck Kim21Soon Ho Um22Department of Pathology, Korea University Medical Center, Seoul 136-701, KoreaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Medical Center, Seoul 136-701, KoreaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Medical Center, Seoul 136-701, KoreaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Medical Center, Seoul 136-701, KoreaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Medical Center, Seoul 136-701, KoreaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Medical Center, Seoul 136-701, KoreaDepartment of Radiology, Korea University Medical Center, Seoul 136-701, KoreaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Medical Center, Seoul 136-701, KoreaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Medical Center, Seoul 136-701, KoreaDepartment of Pathology, Korea University Medical Center, Seoul 136-701, KoreaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Medical Center, Seoul 136-701, KoreaDepartment of Biostatistics, Korea University Medical Center, Seoul 136-701, KoreaDepartment of Radiology, Korea University Medical Center, Seoul 136-701, KoreaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Medical Center, Seoul 136-701, KoreaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Medical Center, Seoul 136-701, KoreaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Medical Center, Seoul 136-701, KoreaDepartment of Surgery, Korea University Medical Center, Seoul 136-701, KoreaDepartment of Surgery, Korea University Medical Center, Seoul 136-701, KoreaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Medical Center, Seoul 136-701, KoreaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Medical Center, Seoul 136-701, KoreaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Medical Center, Seoul 136-701, KoreaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Medical Center, Seoul 136-701, KoreaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Medical Center, Seoul 136-701, KoreaInfiltrative gross morphology of hepatocellular carcinoma (HCC) is known to be associated with poor prognosis, but this is not considered for staging. A total of 774 HCC patients who underwent curative liver resection were retrospectively reviewed and the prognostic significance of infiltrative type HCC was assessed using the American Joint Committee on Cancer (AJCC) and Barcelona Clinic Liver Cancer (BCLC) staging systems. Seventy-four patients (9.6%) had infiltrative HCCs with a higher proportion of multifocal tumors, larger tumors, vessel invasion, increased tumor marker levels, and advanced T-stages than those with nodular HCC (all, <i>p</i><i> </i>< 0.01). Infiltrative morphology was independently associated with lower overall survival (OS), but its impact was significant when the tumor size was ≥ 4 cm (<i>p</i><i> </i>< 0.001). Under current AJCC and BCLC staging criteria, these large infiltrative HCCs were associated with significantly worse OS in early AJCC T-stages (T1b/T2, <i>p</i><i> </i>< 0.001) and BCLC stage A/B (both, p < 0.01) but not in late AJCC (T3/T4) and BCLC C. The reassignment of this subtype to T3 and T4 increased the discriminatory ability of AJCC T-staging with lower AIC values (3090 and 3088 vs. 3109) and higher c-index (0.69 and 0.69 vs. 0.67), respectively (both, p < 0.001). Similarly, the reassignment of large infiltrative HCC to BCLC stages B and C also improved the prognostic performance. Large infiltrative HCCs should be assigned to more advanced stages in current staging systems for their prognostic impact.https://www.mdpi.com/2072-6694/12/9/2589hepatocellular carcinomaAJCC 8th staging systemgross morphologyinfiltrative typenodular typeoverall survival |